Revascularization of unprotected left main coronary artery disease: Strategy selection and systematic risk assessment
Catheterization and Cardiovascular Interventions, 05/09/2012
Palmerini T et al. – A major breakthrough of the SYNTAX trial has been the demonstration of an interaction between the coronary complexity and the revascularization strategy, suggesting that optimal risk stratification is a key element when deciding the best strategy of revascularization in this high–risk group of patients. Multidisciplinary team approach remains essential to provide a balanced information to the patient and to offer the beast treatment option.